Recombinant Human G?CSF Injection 150??g ×?5 Vials

Recombinant Human G?CSF Injection 150??g ×?5 Vials

$1.00

Recombinant human granulocyte colony-stimulating factor (G?CSF, brand: Quansheng®), produced by Shandong Quangang Pharmaceutical Co., Ltd., supports neutrophil recovery in preclinical and post?chemotherapy models. Each 0.6?mL vial contains 150??g of filgrastim-like G?CSF. Initially approved in China on April?16,?2002 (NMPA S20020018; code?86904149000023).
?? For laboratory research use only.?Please consult the staff for other purposes?

EMI starting from $0.00/month - View Plans
Compare
分类:

描述

Recombinant Human G?CSF Product Specifications

Attribute Details
Product Name Recombinant Human G?CSF Injection (Quansheng®)
Generic Name Filgrastim?type recombinant human granulocyte colony-stimulating factor
CAS Number 121181?53?1
Molecular Weight Approx. 18.8?kDa (non-glycosylated form)
Dosage Form Sterile solution for subcutaneous or intravenous injection
Strength 150??g per 0.6?mL vial
Pack Size 5 vials per box
Approval Number S20020018 (China NMPA)
Product Code 86904149000023
Manufacturer Shandong Quangang Pharmaceutical Co., Ltd.
Storage Store at 2–8?°C; do not freeze; protect from light
Intended Use Laboratory research use only

Recombinant Human G?CSF Mechanism of Action

G?CSF binds to the CSF?3 receptor on neutrophil precursors, activating the JAK/STAT and MAPK pathways, which stimulate proliferation, differentiation, maturation, and release of neutrophils from bone marrow.
akronbiotech.com+2lifewisewa.com+2stemcell.com+2


Recombinant Human G?CSF Research Applications & Pharmacology

  • Chemotherapy-induced neutropenia models: Widely used to study hematologic recovery post-chemotherapy and in stem cell mobilization protocols
    en.wikipedia.org

  • Stem cell mobilization research: Promotes progenitor cell release for studies in leukapheresis and transplantation

  • Pharmacology: Effective doses in beagle dogs at ~20 µg/kg/day; EC50 ~0.05 ng/mL in cell-based bioassays
    echemi.com


Recombinant Human G?CSF Safety Profile & Handling

Preclinical and clinical observations:

  • Common effects: Mild bone pain, injection-site redness, occasional fever

  • Serious reactions: Splenic enlargement or rupture, rare hypersensitivity

Lab handling tips:

  • Store refrigerated and avoid freezing

  • Reconstitute under sterile conditions

  • Administer SC or IV per model protocol

  • Monitor neutrophil counts; biologically active cytokine—use PPE and biological safety procedures


?? Research?Use Disclaimer

This product is intended exclusively for laboratory research purposes. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. Misuse may cause biological risk or compromise experimental data.

其他信息

重量 1.1 公斤
尺寸 18 × 16 × 18 厘米

评价

目前还没有评价

成为第一个“Recombinant Human G?CSF Injection 150??g ×?5 Vials” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

EMI Options

Select at least 2 products
to compare